Urgent need for new therapies for colorectal cancer patients with MSS disease – Agenus

Agenus posted on LinkedIn:

“Andrew Wortmann, Creative Director at Fight Colorectal Cancer, emphasizes the urgent need for new therapies for the 95% of colorectal cancer patients with MSS disease. Driving innovation and developing new treatment options are essential for individuals living with colorectal cancer.”

Video attached to the post.
Source: Agenus/LinkedIn

Andrew Wortmann is the Director of Innovative Marketing and Community Engagement Manager at Fight Colorectal Cancer. He was the owner of Andrew Wortmann Designs. He has also served as a Marketing Coordinator at BNIM.